Podcasts about cancer risk

Today, I am delighted to connect with Dr. Elisa Port, a talented breast surgeon with a passion for helping women better understand breast cancer, breast health, and the science behind screening, diagnosis, and treatment. She's the chief of breast surgery for Mount Sinai Health System in New York, a professor of surgery at Mount Sinai's Icahn School of Medicine, and the author of The Breast Advice. In our conversation, we explore breast cancer risk factors, various screening mechanisms and their impact on dense breasts, and the role of diagnosis and pathology, including DCIS. We also discuss menopause symptom management, anti-hormone and targeted treatments, immunotherapy, de-escalation, and why a personalized approach to breast cancer treatment is so important.  Stay tuned for a truly informative conversation with Dr. Port. With her infectious optimism, she has a wonderful way of translating the science and the research in her book, making it accessible and putting the statistics into context so the information feels far less scary than it otherwise might. IN THIS EPISODE, YOU WILL LEARN: How 90% of women diagnosed with breast cancer have no family cancer history How body weight and alcohol can influence breast cancer risk Why Dr. Port recommends annual mammograms beginning at age 40 for most women Dr. Port may disagree with recommendations against breast self-exams Why women with dense breasts may benefit from supplemental ultrasound or MRI in addition to mammography Unvalidated breast screening tests may lead to false positives, unnecessary testing, procedures, anxiety, and expense. What DCIS is, and how it influences treatment decisions Why an individualized approach is essential when using SERMs, SERDs, and aromatase inhibitors How Oncotype testing helps to identify women who may safely avoid chemotherapy Bio: Dr Elisa Port Dr. Elisa Port, MD, is chief of breast surgery at Mount Sinai Health System, which encompasses seven different breast centers. Her team performs over a thousand breast surgical procedures each year. She is also the director of the Dubin Breast Center, a state-of-the-art breast center in Manhattan that opened in April 2011. She personally consults with thousands of patients and performs hundreds of operations each year. Dr. Port is a trusted voice in the media and a sought-after speaker. She has been featured in The New York Times, NPR, CBS, Today, Mornings with Maria, and Pix11. In addition to her media presence, Dr. Port regularly speaks at public events and is invited to present at conferences and panels across the country. She lives in Manhattan with her husband and two dogs. Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Purchase Cynthia's book, The Menopause Gut. Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Elisa Port On her website On her personal Instagram  Breast Advice MD on Instagram The Breast Advice Substack

Outsmarting Cancer: Risk Reduction and the Power of Prevention (Johns Hopkins University Press, 2026) reframes one of the most pressing medical challenges of our time: how to prevent cancer. In this timely and accessible book, physician and medical researcher Adam Barsouk, MD, presents a sweeping examination of cancer's true origins-biological, environmental, dietary, infectious, industrial, occupational, and behavioral-and makes a compelling case for why cancer prevention must become a central priority in public and personal health. With personal stories from his clinical practice and the latest research, Dr. Barsouk explains why more people are getting diagnosed with cancer-and at younger ages-than ever before. This book explores a wide range of overlooked and misunderstood risk factors, as well as how inequities in diagnosis, treatment, and prevention disproportionately impact underserved populations. Unlike typical cancer books that focus narrowly on diet or organ-specific disease, Outsmarting Cancer takes a comprehensive, systems-level view, urging readers to look beyond the symptoms and target the root causes. Dr. Barsouk explores the role of genetic predisposition to cancer alongside environmental, lifestyle, and public policy influences that may contribute to developing the disease. With rigorous scientific insight, he offers real-world, evidence-based strategies to reduce cancer risk in practical, meaningful ways. Honest, urgent, and empowering, Outsmarting Cancer challenges readers to rethink how we talk about cancer and how we can reduce its burden before it begins. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Outsmarting Cancer: Risk Reduction and the Power of Prevention (Johns Hopkins University Press, 2026) reframes one of the most pressing medical challenges of our time: how to prevent cancer. In this timely and accessible book, physician and medical researcher Adam Barsouk, MD, presents a sweeping examination of cancer's true origins-biological, environmental, dietary, infectious, industrial, occupational, and behavioral-and makes a compelling case for why cancer prevention must become a central priority in public and personal health. With personal stories from his clinical practice and the latest research, Dr. Barsouk explains why more people are getting diagnosed with cancer-and at younger ages-than ever before. This book explores a wide range of overlooked and misunderstood risk factors, as well as how inequities in diagnosis, treatment, and prevention disproportionately impact underserved populations. Unlike typical cancer books that focus narrowly on diet or organ-specific disease, Outsmarting Cancer takes a comprehensive, systems-level view, urging readers to look beyond the symptoms and target the root causes. Dr. Barsouk explores the role of genetic predisposition to cancer alongside environmental, lifestyle, and public policy influences that may contribute to developing the disease. With rigorous scientific insight, he offers real-world, evidence-based strategies to reduce cancer risk in practical, meaningful ways. Honest, urgent, and empowering, Outsmarting Cancer challenges readers to rethink how we talk about cancer and how we can reduce its burden before it begins. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Outsmarting Cancer: Risk Reduction and the Power of Prevention (Johns Hopkins University Press, 2026) reframes one of the most pressing medical challenges of our time: how to prevent cancer. In this timely and accessible book, physician and medical researcher Adam Barsouk, MD, presents a sweeping examination of cancer's true origins-biological, environmental, dietary, infectious, industrial, occupational, and behavioral-and makes a compelling case for why cancer prevention must become a central priority in public and personal health. With personal stories from his clinical practice and the latest research, Dr. Barsouk explains why more people are getting diagnosed with cancer-and at younger ages-than ever before. This book explores a wide range of overlooked and misunderstood risk factors, as well as how inequities in diagnosis, treatment, and prevention disproportionately impact underserved populations. Unlike typical cancer books that focus narrowly on diet or organ-specific disease, Outsmarting Cancer takes a comprehensive, systems-level view, urging readers to look beyond the symptoms and target the root causes. Dr. Barsouk explores the role of genetic predisposition to cancer alongside environmental, lifestyle, and public policy influences that may contribute to developing the disease. With rigorous scientific insight, he offers real-world, evidence-based strategies to reduce cancer risk in practical, meaningful ways. Honest, urgent, and empowering, Outsmarting Cancer challenges readers to rethink how we talk about cancer and how we can reduce its burden before it begins. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/environmental-studies

Outsmarting Cancer: Risk Reduction and the Power of Prevention (Johns Hopkins University Press, 2026) reframes one of the most pressing medical challenges of our time: how to prevent cancer. In this timely and accessible book, physician and medical researcher Adam Barsouk, MD, presents a sweeping examination of cancer's true origins-biological, environmental, dietary, infectious, industrial, occupational, and behavioral-and makes a compelling case for why cancer prevention must become a central priority in public and personal health. With personal stories from his clinical practice and the latest research, Dr. Barsouk explains why more people are getting diagnosed with cancer-and at younger ages-than ever before. This book explores a wide range of overlooked and misunderstood risk factors, as well as how inequities in diagnosis, treatment, and prevention disproportionately impact underserved populations. Unlike typical cancer books that focus narrowly on diet or organ-specific disease, Outsmarting Cancer takes a comprehensive, systems-level view, urging readers to look beyond the symptoms and target the root causes. Dr. Barsouk explores the role of genetic predisposition to cancer alongside environmental, lifestyle, and public policy influences that may contribute to developing the disease. With rigorous scientific insight, he offers real-world, evidence-based strategies to reduce cancer risk in practical, meaningful ways. Honest, urgent, and empowering, Outsmarting Cancer challenges readers to rethink how we talk about cancer and how we can reduce its burden before it begins. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/sociology

Outsmarting Cancer: Risk Reduction and the Power of Prevention (Johns Hopkins University Press, 2026) reframes one of the most pressing medical challenges of our time: how to prevent cancer. In this timely and accessible book, physician and medical researcher Adam Barsouk, MD, presents a sweeping examination of cancer's true origins-biological, environmental, dietary, infectious, industrial, occupational, and behavioral-and makes a compelling case for why cancer prevention must become a central priority in public and personal health. With personal stories from his clinical practice and the latest research, Dr. Barsouk explains why more people are getting diagnosed with cancer-and at younger ages-than ever before. This book explores a wide range of overlooked and misunderstood risk factors, as well as how inequities in diagnosis, treatment, and prevention disproportionately impact underserved populations. Unlike typical cancer books that focus narrowly on diet or organ-specific disease, Outsmarting Cancer takes a comprehensive, systems-level view, urging readers to look beyond the symptoms and target the root causes. Dr. Barsouk explores the role of genetic predisposition to cancer alongside environmental, lifestyle, and public policy influences that may contribute to developing the disease. With rigorous scientific insight, he offers real-world, evidence-based strategies to reduce cancer risk in practical, meaningful ways. Honest, urgent, and empowering, Outsmarting Cancer challenges readers to rethink how we talk about cancer and how we can reduce its burden before it begins. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/science

Outsmarting Cancer: Risk Reduction and the Power of Prevention (Johns Hopkins University Press, 2026) reframes one of the most pressing medical challenges of our time: how to prevent cancer. In this timely and accessible book, physician and medical researcher Adam Barsouk, MD, presents a sweeping examination of cancer's true origins-biological, environmental, dietary, infectious, industrial, occupational, and behavioral-and makes a compelling case for why cancer prevention must become a central priority in public and personal health. With personal stories from his clinical practice and the latest research, Dr. Barsouk explains why more people are getting diagnosed with cancer-and at younger ages-than ever before. This book explores a wide range of overlooked and misunderstood risk factors, as well as how inequities in diagnosis, treatment, and prevention disproportionately impact underserved populations. Unlike typical cancer books that focus narrowly on diet or organ-specific disease, Outsmarting Cancer takes a comprehensive, systems-level view, urging readers to look beyond the symptoms and target the root causes. Dr. Barsouk explores the role of genetic predisposition to cancer alongside environmental, lifestyle, and public policy influences that may contribute to developing the disease. With rigorous scientific insight, he offers real-world, evidence-based strategies to reduce cancer risk in practical, meaningful ways. Honest, urgent, and empowering, Outsmarting Cancer challenges readers to rethink how we talk about cancer and how we can reduce its burden before it begins. Learn more about your ad choices. Visit megaphone.fm/adchoices

Could 12 everyday high-fibre foods really help lower your risk of heart disease, dementia and some cancers?  The world is obsessed with protein, but fewer than 1 in 10 people eat enough fibre. But this year, fiber is making an unexpected comeback. In this episode, legendary chef Hugh Fearnley-Whittingstall and ZOE's Chief Scientist Professor Sarah Berry ask whether fibre is another food trend or a powerful part of our diet that we have overlooked. Taking inspiration from Hugh's new book High Fibre Heroes, they explore how fibre feeds your gut microbes, helps you feel full and slows the release of sugar into your blood. And, by the end of the episode, you'll know how to eat more fibre without costly ingredients or difficult recipes, and how to turn familiar foods into simple meals packed with flavour. Are you buying more protein while overlooking the foods your body may need most? The answer could already be in your cupboard, freezer or fridge.

Can hot coffee give you cancer? Can candles? Are the subtle risks in your daily environment quietly impacting your long-term health? In this episode, we sit down with Dr. Amar Rewari to uncover the crucial connection between environmental toxins, proactive health screenings, and preventive medicine. From everyday household products and hidden indoor pollutants to the non-negotiable health screenings every adult should have on their radar, Dr. Rewari breaks down complex medical science into actionable, day-to-day strategies to lower your risk of cancer.   Whether you're looking to optimize your family's wellness, safeguard your home environment, or take charge of your preventive healthcare routine, this conversation offers an essential roadmap for longevity. For more information about Dr. Rewaris go to: amarrewari.com Or Listen to his podcast: Value Health Voices Podcast  Follow him on:  Instagram: @dramarexplains   On X: DrAmarExplains   On TikTok: @doctoramarexplains   On LinkedIn: Amar Rewari Md   Follow us on Instagram: @every.body.talks @jenngiamo @schully Subscribe to our YouTube channel! Don't forget to subscribe to the podcast for free wherever you're listening. Apple Podcasts Spotify Be sure to leave a 5 star rating! It really helps grow the show. If you like the show, telling a friend about it would be amazing!

He reveals how food packaging, seafood, and meat concentrate microplastics and forever chemicals, risking brain and endocrine health. #Microplastics #FoodToxins #BrainHealth #EnvironmentalHealth

In this episode, we explore what current research tells us about the relationship between farming and cancer in Iowa. Joining the conversation is Caroline Powell of the Iowa Cancer Consortium, who discusses findings from the 2026 Cancer in Iowa report and shares insights from her research on cancer knowledge and prevention in agricultural communities. Together, we examine cancer risks specific to farming, separate fact from speculation, and highlight practical, evidence-based steps farmers and their families can take to reduce cancer risk over a lifetime. Whether you live, work, or care about rural health, this episode provides valuable information to help you make informed decisions about cancer prevention. Episode ResourcesCancer in Iowa, 2026 Report, Iowa Cancer RegistryAgricultural Health Study, NIHIowa Cancer ConsortiumAg Health 101, GPCAH

From ovarian to prostate cancer, Dr. Barnard outlines why dairy increases risk—and how plant-based swaps can help. #DairyDangers #FertilityHealth #CancerRisk

Eager to understand why everyone is suddenly talking about fiber? Ethan sits down with Paige to break down the new food pyramid, why fiber has become such a hot topic, and what actually matters for long-term health. They discuss whole food sources of fiber, whether supplements and gummies are worth taking, the role of protein, complete versus incomplete proteins, and why food labels can be misleading. Ethan also explains how fiber may support satiety, gut health, and overall wellness, while keeping expectations grounded in real-world nutrition. For more insights from Ethan, subscribe to his newsletter: https://ethansuplee.substack.com/subscribeSHOW HIGHLIGHTS00:00 Welcome and a Funny Wedding Ring Story 03:24 Why Fiber Is the New Nutrition Focus 05:23 Does the New Food Pyramid Really Matter? 06:13 The Best Whole Food Sources of Fiber 08:26 Fiber Supplements and Gummies 10:13 Vegetables That Pack More Fiber 11:07 Fiber, Gut Health, and Cancer Risk 14:01 Understanding Protein Labels and Complete Protein 16:14 Comparing Real Nutrition Labels 20:00 What Does "Processed Food" Really Mean? 21:34 How Much Fiber Do You Actually Need? 24:02 Can Fiber Help With Weight Loss? 25:43 Fiber Around Exercise and Recovery 27:09 Whole Foods Versus Convenient Protein Snacks 29:03 Airport Eating and Staying on Track Hosted on Acast. See acast.com/privacy for more information.

If most glyphosate exposure comes from food, how much do we actually absorb?

Researchers followed more than 1.39 million adults and found that advanced cardiovascular-kidney-metabolic (CKM) disease was strongly associated with higher cancer risk, especially once people reached the more severe stages tied to insulin resistance, kidney dysfunction, and cardiovascular disease Cancer incidence rose from 81.2 cases per 10,000 person-years in the healthiest group to more than 250 cases per 10,000 person-years in advanced CKM stages (an increase that narrowed to roughly 25% to 30% after adjusting for age and other factors), showing how rapidly risk accelerates once multiple metabolic systems begin failing together Chronic inflammation, insulin resistance and excess dysfunctional body fat may help create a biologic environment associated with higher rates of colorectal, lung, pancreatic, liver, bladder, kidney, and hormone-related cancers Younger adults under 65 with advanced CKM disease showed a 45% higher cancer risk, challenging the idea that metabolic-driven cancer only develops late in life after decades of decline Lowering seed oil intake, improving insulin sensitivity through movement, supporting mitochondrial energy production with sunlight and tracking markers such as HOMA-IR and blood pressure may help slow metabolic deterioration before it reaches the dangerous tipping point tied to higher cancer risk

The headlines say your thyroid medication might cause cancer. Before you stop taking it, read this. A 2021 study of over 600,000 people found that long-term levothyroxine users had higher rates of several cancers. That number spread quickly, and for good reason. It sounds alarming. But the study had a critical flaw: it could not separate the effect of the medication from the autoimmune disease that caused people to need it in the first place. In this episode, Evan H. Hirsch, MD breaks down what the research actually found, why Hashimoto's is likely behind the numbers, and what to focus on if you want your health to actually improve. In this episode, you'll learn: Why the study cannot prove levothyroxine caused the cancer, and what it was actually measuring How Hashimoto's thyroiditis, not the medication, likely explains the elevated cancer risk What the study got wrong about who it compared, and why that changes the conclusion Why switching to natural or desiccated thyroid does not reduce your cancer risk What drives autoimmune thyroid disease, and what you can actually do about it Why stopping thyroid medication is not the answer if you want to improve your health Discover your fatigue score and the root causes keeping you stuck: https://myfatiguescore.com Free Fatigue Masterclass: https://fixyourfatigue.com See real results: https://energymdmethod.com/results Chapters: 00:00 - Does Levothyroxine Cause Cancer? 00:31 - What the Research Actually Found 01:22 - Correlation vs. Causation Explained 02:39 - Hashimoto's and Cancer Risk 03:43 - The Toxic 5 and Autoimmune Thyroid Disease 04:50 - Should You Stop Taking Levothyroxine? 06:00 - The Real Root Cause to Address Subscribe to the EnergyMD Podcast for weekly conversations with leading experts on resolving ME/CFS and Long COVID by addressing the real root causes. . For more information about Evan and his program, Click Here.  Prefer to watch on Youtube? Click Here.  Please note that any information in this episode is for educational purposes only and does not constitute medical advice.

Integrative oncologist Dr. Nina Fuller-Shavel joins me to explain why cancer rates are climbing in midlife women, even those who look healthy on paper. WHAT YOU'LL LEARN -       Why cancer rates are rising even in midlife women who look and feel healthy -       The gut-estrogen connection: how your microbiome affects hormone-driven cancer risk -       The 3 simple interventions that cut cancer risk by 60% in a landmark trial -       How strength training lowers inflammation and disease risk -       Why lifetime estrogen exposure matters more than the estrogen drop in perimenopause -       Why standard HRT dosing gets it wrong, and what blood levels to actually ask for -       Why TSH alone can't tell the full thyroid story, and what a full panel should include -       How chronic stress and trauma quietly drive long-term disease risk TIMESTAMPS 00:00 Why Cancer Rates Are Rising in Midlife Women 09:44 The Vitamin D, Omega-3 and Strength Training Protocol That Cut Cancer Risk by 60% 18:17 Perimenopause, Estrogen Exposure and Why HRT Dosing Alone Isn't the Answer to Cancer Risk 28:10 Hashimoto's, Thyroid Antibodies and Why TSH Alone Is Misleading You in Perimenopause 36:02 Inflammation, Cortisol and Chronic Stress: The Hidden Drivers of Disease Risk in Midlife 43:57 Trauma, Boundaries and Why Saying No Is a Non-Negotiable in Midlife Health 51:35 Full Body MRIs, Genetic Testing and Polygenic Risk Scores: What's Actually Worth Doing 59:03 Wearables, CGMs and the One Longevity Message Every High-Achieving Woman Needs to Hear .  VALUABLE RESOURCES ●      Synthesis Clinic (Dr. Nina's integrative oncology practice)

In this weeks cannabis news we discuss the following stories: Macky: Cannabis smuggler knows most of his drugs mules 'will get caught' - BBC News  Smee: Strain Review Roundup What Worth Smoking in July 2026 Dr.Margaret: Heavy marijuana smoking may increase cancer risk, researchers warn | ScienceDaily   This week we discuss a BBC report featuring a convicted cannabis smuggler who admits that many of the people recruited as drug mules are expected to get caught, raising questions about organised crime and the people being exploited to carry out these operations. Smee joins us with his latest strain roundup, highlighting what's been impressing him and what's worth checking out this month. Dr. Margaret looks at new research investigating whether heavy, long-term cannabis use may be associated with an increased risk of certain cancers, and we discuss what the study actually found, its limitations, and why it's important to look beyond the headlines. We also have an interesting conversation about the future of cannabis reform in the UK, following reports that Andy Burnham has reached out to Gary Youds and his team for advice on cannabis policy. Could this signal a serious shift in the conversation around legalisation if Burnham becomes Britain's next Prime Minister? We share our thoughts on what it could mean for patients, home growers, and the wider cannabis community. Another episode packed with news, science, politics, and cannabis conversation from around the world.

More and more blood tests to screen for cancer are coming on the market, with a new one looking at proteins in the blood helping identify who is at risk to develop lung cancer. Kimmel Cancer Center director William Nelson … How often can a blood test predict cancer risk? Elizabeth Tracey reports Read More »

GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, … How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read More »

For some types of cancer obesity is clearly a risk factor. Now a new study shows that when people with obesity take a GLP-1 agonist to lose weight, they also reduce their risk for these cancers. Kimmel Cancer Center director … How do GLP-1 agonists compare against other strategies for weight reduction and cancer risk reduction? Elizabeth Tracey reports Read More »

In this episode of the Breast Cancer Now podcast, we explore the role of genetics in cancer risk, including BRCA1 and BRCA2 gene mutations, specifically in Jewish populations.Naomi shares her powerful story after discovering she carries the BRCA2 gene mutation following the loss of her mum to ovarian cancer. With an 80% lifetime risk of breast cancer, She faced life-changing decisions, and opted for risk-reducing surgery.Naomi speaks about what it's like to live with that knowledge, how it shaped her choices, and why taking preventative action gave her a sense of control. She also shares the impact of her gene mutation on her children, and how they've dealt with it as a family.We're also joined by Josh from Jnetics, a Jewish genetic disorders charity, who explains the science behind BRCA gene mutations, why they increase cancer risk, and why they are more common in people with Jewish ancestry. He also outlines how testing works, who may be eligible, and what support is available.Breast Cancer NowWebsite: https://breastcancernow.orgFree helpline: 0808 800 6000Jewish BRCA Testing Programme (NHS England)Register interest: https://www.jewishbrca.orgHelpline: 020 3437 6001Jneticshttps://www.jnetics.orgChai Cancer Carehttps://www.chaicancercare.orgYou can also watch this episode on YouTube.Key topics:1:29 Getting to know Naomi and Josh4:00 A history of cancer in Naomi's family7:50 Naomi is tested for the BRCA gene mutation9:35 What is a genetic mutation or gault?12:20 Why is the BRCA gene mutation more common in Jewish populations?17:24 What is BRCA, how does it work, and why does it break?20:38 Naomi's increased risk of cancer23:32 Naomi makes the choice to have risk-reducing surgery27:01 The psychological impact of risk-reducing surgery28:34 Support for carriers of gene mutations31:53 How to get tested for BRCA gene mutations35:52 Coping with the fear of having genetic testing37:52 Naomi decides how to deal with her daughters potentially being BRCA carriers39:47 Dealing with feelings of guilt passing on a genetic mutation to a child41:15 Preventing gene mutations with IVF42:20 Research into fixing faulty genes44:06 Cultural barriers to genetic testing within Jewish populations46:51 Hope for the future of genetic mutations50:08 More information for people with Jewish heritageBRCA gene, BRCA2, breast cancer risk, genetic testing UK, hereditary cancer, ovarian cancer risk, mastectomy prevention, cancer genetics, Jewish BRCA, NHS genetic testing, breast cancer awareness UK

After a Barrett's esophagus diagnosis, many patients ask: What happens next—and do I need treatment? In this episode, foregut surgeon Dr. Caitlin Houghton of Keck Medicine of USC explains how Barrett's esophagus is treated in the United States and how doctors work to reduce the risk of progression to esophageal cancer. In this episode, you'll learn: • How doctors decide when treatment is needed • The role of reflux control, medications, and lifestyle changes • When endoscopic eradication therapy (EET) may be recommended • When surgery may be considered • Why ongoing surveillance is important for long-term care If you or someone you love has Barrett's esophagus, chronic GERD, or long-term acid reflux, this episode provides practical, evidence-based guidance to help you better understand your options. This episode is part of a 4-part patient education series sponsored by Castle Biosciences and produced by Gastro Girl in collaboration with leading U.S. clinicians dedicated to improving outcomes for patients with Barrett's esophagus.  

Dr. Matthew Goldberg, Senior Vice President for Medical at Castle Biosciences, discusses the uncertainty clinicians face when determining treatments for skin cancer due to the limitations of traditional pathology reports. Castle's gene expression profile tests were developed to improve the accuracy of risk stratification for patients with cutaneous melanoma and high-risk cutaneous squamous cell carcinoma. These tests provide prognostic information by analyzing the tumor's RNA, offering more granular and accurate risk assessment and informing about the intensity of follow-up and long-term risk management strategies. Matthew explains, "So this is an important topic for dermatologists who are really on the front lines of skin cancer diagnosis and management for patients who are confronting skin cancer today. I'm a board-certified dermatologist and dermatopathologist by training. And to me, I think that the core uncertainty is centered around some of the known limitations around the prognostic accuracy of pathology. That's kind of worth unpacking here, but I think what it comes down to is that dermatologists are involved in identifying concerning skin lesions, identifying and, through biopsy, taking a skin sample, and finding skin cancers."   "Dermatopathologists are the collaborative colleagues who interpret the skin biopsy samples and return the pathological diagnoses to the dermatologist. For the treating clinician, the key task is to understand the implications of the types of skin cancers identified in this process to determine the most appropriate, risk-aligned downstream management for patients with these skin cancers." "So Castle Biosciences has developed a range of tests that are really focused on impactful skin cancers that are some of the biggest challenges for dermatologists and the patients that we serve in the clinic, specifically around cutaneous melanoma with the DecisionDx-Melanoma gene expression profile test and also high-risk cutaneous squamous cell carcinomas with the DecisionDx-SCC test." #CastleBiosciences #SkinCancer #CancerCare #HealthcareInnovation #Dermatology #MolecularDiagnostics #PrecisionMedicine #RiskStratification #ClinicalDecisionMaking #DigitalPathology #Oncology #Melanoma #SquamousCellCarcinoma #GeneExpression #SharedDecisionMaking castlebiosciences.com Listen to the podcast here  

Dr. Matthew Goldberg, Senior Vice President for Medical at Castle Biosciences, discusses the uncertainty clinicians face when determining treatments for skin cancer due to the limitations of traditional pathology reports. Castle's gene expression profile tests were developed to improve the accuracy of risk stratification for patients with cutaneous melanoma and high-risk cutaneous squamous cell carcinoma. These tests provide prognostic information by analyzing the tumor's RNA, offering more granular and accurate risk assessment and informing about the intensity of follow-up and long-term risk management strategies. Matthew explains, "So this is an important topic for dermatologists who are really on the front lines of skin cancer diagnosis and management for patients who are confronting skin cancer today. I'm a board-certified dermatologist and dermatopathologist by training. And to me, I think that the core uncertainty is centered around some of the known limitations around the prognostic accuracy of pathology. That's kind of worth unpacking here, but I think what it comes down to is that dermatologists are involved in identifying concerning skin lesions, identifying and, through biopsy, taking a skin sample, and finding skin cancers."   "Dermatopathologists are the collaborative colleagues who interpret the skin biopsy samples and return the pathological diagnoses to the dermatologist. For the treating clinician, the key task is to understand the implications of the types of skin cancers identified in this process to determine the most appropriate, risk-aligned downstream management for patients with these skin cancers." "So Castle Biosciences has developed a range of tests that are really focused on impactful skin cancers that are some of the biggest challenges for dermatologists and the patients that we serve in the clinic, specifically around cutaneous melanoma with the DecisionDx-Melanoma gene expression profile test and also high-risk cutaneous squamous cell carcinomas with the DecisionDx-SCC test." #CastleBiosciences #SkinCancer #CancerCare #HealthcareInnovation #Dermatology #MolecularDiagnostics #PrecisionMedicine #RiskStratification #ClinicalDecisionMaking #DigitalPathology #Oncology #Melanoma #SquamousCellCarcinoma #GeneExpression #SharedDecisionMaking castlebiosciences.com Download the transcript  

Most of us fall short on fiber, even when we consider ourselves healthy eaters, and it might be impacting us more than we realize. In this episode, Dr. Lisa Oldson breaks down what the research actually shows about fiber's role in weight loss, heart health, cancer risk, and longevity, and why food sources are better than supplements. Plus, five simple ways to start increasing your fiber today without overhauling your entire diet. Thanks for listening! If you'd like more support during your SMART weight loss & health focused journey, sign up for our FREE newsletter, or check out our program at: www.SmartWeightLossCoaching.com. We would love to help you reach your happy weight, and transform the way you talk to yourself about your body and the number on the scale. Negative thoughts about yourself don't have to take up so much brain space, and we'd be honored to help you reframe those thoughts. Also, we'd be grateful if you'd follow us and share our podcast with your friends & family. We're here to help you live longer, healthier, and lose weight the SMART way! This episode was produced by The Podcast Teacher: www.ThePodcastTeacher.com.The Smart Weight Loss Coaching Podcast is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider before starting, stopping, or changing any medication.

In this episode Dr. Sandeep Malik walks through evidence-based cancer prevention strategies you can begin today and explains why prevention matters for long-term health. He covers lifestyle risk reduction, the role of screening, and vaccine-based prevention in plain language.

Years after working in smoky, sooty conditions controlling fires, workers can experience the adverse health effects of the job. Proving the link can be difficult. But now in British Columbia, wildland firefighters are getting early cancer screening and expanded workers compensation coverage for cancer. With climate change contributing to the hot, dry conditions that lead to longer, more intense fire seasons, we explore what else can be done to reduce the exposure to carcinogens these front-line workers face.

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate and high-risk patients? In this episode of BackTable, Dr. Bogdana Schmidt interviews urologists Dr. Kristen Scarpato and Dr. Sunil Patel to explore the complexities of diagnosis and risk assessment in non–muscle invasive bladder cancer (NMIBC). They discuss the real-world challenges of pathology interpretation, risk-group assignment, evolving diagnostic tools, and the impact these factors have on treatment decisions and patient outcomes. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Johnson & Johnson. --- Timestamps00:00 - Introduction01:02 - Risk Stratification07:22 - Upstaging to High Risk10:06 - Calculators and Patient Education15:22 - Specific Tests Use Cases18:50 - Conflicting Biomarker Results21:36 - Adjunct Tests and Counseling24:03 - Recurrence After Chemo Next Steps27:01 - Escalation Deescalation Balance32:48 - Future Research Priorities35:43 - Biology Based Risk Stratification38:03 - Clinical Pearls and Wrap Up --- More about this episodeThe conversation highlights the heterogeneity of intermediate-risk disease, the role and importance of expert pathology over-reads, and the need to accurately document the risk category for ongoing care. They discuss selective use of urinary and genomic assays and how these tests fit alongside cystoscopy and blue light endoscopy. Practical treatment approaches are reviewed, including when to use intravesical gemcitabine or BCG, managing care during BCG shortages, and balancing escalation versus de-escalation of therapy. Additional topics include strategies for long-term surveillance, upper tract imaging, rising rates of bladder cancer in younger patients, and why thorough TURBT and strong patient-provider communication remain central to optimal management. --- Resources The Memorial Studyhttps://www.mskcc.org/cancer-care/clinical-trials/19-288 The BRIDGE Studyhttps://www.nejm.org/doi/full/10.1056/NEJMoa1501035 --- BackTable Urology is the go-to podcast for urologists, urologic oncologists, and urogynecologists. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty.► https://www.backtable.com/app

What Causes Cancer? The Truth Most Doctors Don't Talk AboutIn this episode of Intellectual Medicine, Dr. Stephen Petteruti explores the relationship between cancer, metabolism, sugar, insulin, body fat, and prostate cancer progression. He discusses the Warburg theory, which suggests that cancer may begin with dysfunctional mitochondrial metabolism, and compares it with the later focus on genetic causes of cancer. While he argues that the idea of “starving cancer” by eliminating sugar is too simplistic, he also emphasizes that metabolic health plays a real role in cancer risk and progression.The episode focuses heavily on prostate cancer, which Dr. Petteruti describes as unique compared with other cancers. He argues that conventional approaches often overlook the environment in which cancer develops, including excess body fat, high insulin, elevated blood sugar, inflammation, and poor metabolic health. He also discusses tests such as fasting insulin, hemoglobin A1c, and continuous glucose monitoring, as well as the importance of nutritional and behavioral change. The episode closes with a warning against extreme diets, oversimplified supplement advice, and one-size-fits-all cancer theories.Timestamps:(00:00) What Causes Cancer?(01:02 )The Warburg Theory(02:14) Genetics vs. Metabolism(04:22) Why “Starving Cancer” Is Too Simplistic(05:42) Body Fat, Insulin, and Prostate Cancer(08:30) Tests That May Help Assess Metabolic Health(10:47) Food, Weight Loss, and Cancer Risk(13:42) The Anti-Cancer Lifestyle(15:04) Toxins, Viruses, and Parasites(16:15) NAD, Mitochondria, and Supplement Caution(17:33) Growth Hormone, IGF-1, and Cancer Risk(19:12) Why Extreme Dieting Is Not the AnswerEnjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Book: Fight Cancer Like a Man: https://tinyurl.com/FightLikeAManBookDr. Steve's email newsletter: https://drstephenpetteruti.substack.com/subscribePodcast show notes : https://www.intellectualmedicine.com/podcast-notesMember exclusive content: https://tinyurl.com/DrPetterutiMemberLearn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:⁠Instagram: ⁠https://www.instagram.com/dr.stephenpetteruti/⁠ Facebook: ⁠https://www.facebook.com/dr.stephenpetteruti⁠ Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.

Dr. Kassam explains how hormones, IGF-1, nitrates, and saturated fat in dairy and meat promote cancer growth and DNA damage. #CancerRiskFactors #DairyAndCancer #MeatAndCancer #NutritionMechanisms

Eating your fruits and vegetables is one of the easiest ways to care for…

Explore how IGF-1, saturated fat, and keto diets can fuel cancer growth, while plant-based diets offer protection. #CancerRisk #KetoMyths #IGF1 #PlantProtection

Unprocessed red meat and cancer risk remains one of the most debated topics in nutrition science, partly because the evidence is often presented in overly simplistic terms. The key question is not whether to adopt a vague "balanced" position on red meat, but whether the evidence clearly identifies intake levels at which colorectal cancer risk increases and whether controlled human trials support plausible mechanisms for that risk. A second issue is whether claims that fibre, vegetables, or an otherwise "healthy diet" can neutralise high red meat intake are actually supported by the mechanistic evidence, or whether they overstate what dietary context can plausibly offset. In this episode, Danny and Alan examine the evidence base by moving beyond the usual epidemiology-only debate. They discuss why regional intake patterns and dose thresholds matter, then explore controlled human feeding studies showing how higher red meat intake can increase endogenous N-nitroso compound formation, faecal water genotoxicity, and other mechanistic biomarkers linked to colorectal carcinogenesis. Timestamps: [01:11] Defining the exposure and outcome [02:34] Carcinogen labels explained [07:54] Epidemiology and dose thresholds [14:04] Interpreting null findings [19:09] Bingham 1996 nitroso study [25:20] Hughes dose response trial [33:49] Cross 2003 heme iron mechanism [42:55] Fecal water genotoxicity [55:42] Tumor mutational signatures [59:38] What we can conclude now [01:04:10] Practical intake recommendations [01:08:41] Key ideas segment (premium-only) Links: Go to episode page (includes links to studies mentioned) Subscribe to Sigma Nutrition Premium Join the Sigma newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course

A headline like “weight loss drugs may reduce breast cancer risk” grabs attention fast, but the real story lives in the fine print. We take you through a new Penn Medicine study that observed lower breast cancer rates among women with overweight or obesity who used GLP-1 medications, then we translate what that finding actually means in plain language. Observational data can reveal a signal worth studying, but it cannot prove the medication caused the outcome, and that distinction matters for your decisions and your expectations. We also zoom out to the bigger why: obesity is not just about body size. Fat tissue is biologically active, shaping chronic inflammation, estrogen exposure after menopause, insulin resistance, and even how well the immune system spots abnormal cells. Those pathways help explain why obesity is linked to many cancers, including postmenopausal breast cancer, and why researchers are curious whether effective obesity treatment could shift risk over time. Then we get practical. We review what stronger evidence from randomized controlled trials says so far: GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound do not appear to increase breast cancer risk in the available trial data, even though most trials were not designed to study cancer outcomes for many years. We also discuss why newer studies seem most suggestive for hormone receptor positive breast cancer, along with the leading theories: weight loss itself, improved metabolic health and insulin signaling, reduced inflammation, and the still-unclear possibility of direct GLP-1 effects in cancer biology. If you like evidence-based medicine with real-world context (and a little Philly-life banter), subscribe, share this episode with a friend, and leave a review so more people can find the show. What question do you want answered next about GLP-1s, obesity treatment, or cancer risk?ReferencesRisk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-Analysis. Ko A, Chang YC, Bahar F, et al. Annals of Internal Medicine. 2025;. doi:10.7326/ANNALS-25-02237.Do GLP-1 Receptor Agonists Increase the Risk of Breast Cancer? A Systematic Review and Meta-Analysis. Piccoli GF, Mesquita LA, Stein C, et al. The Journal of Clinical Endocrinology and Metabolism. 2021;106(3):912-921. doi:10.1210/clinem/dgaa891.Glucagon-Like Peptide 1 Receptor Agonists and Cancer Risk: The Good, the Bad and the Unknown. Mannucci E, Dicembrini I. Nature Reviews. Clinical Oncology. 2026;23(6):459-470. doi:10.1038/s41571-026-01135-0.GLP-1 Agonists Are Associated With a Significant Reduction in Breast Cancer Incidence in Women. McDonald ES, Gillis LB, Gabriel P, et al. JCO Oncology Practice. 2026;:101200OP2600485. doi:10.1200/OP-26-00485.GLP-1 therapy and hormone receptor–positive breast cancer risk and survival: A real-world analysis.. Shah Z, Hundal J, Afridi S, et al. Journal of Clinical Oncology. 2026;44(Suppl 16):10548. doi:10.1200/JCO.2026.44.16_suppl.10548.Survival and Recurrence With GLP-1 Receptor Agonists in Breast Cancer. Tatum KL, Dahman B, Stevenson A, et al. JAMA Network Open. 2026;9(5):e2612133. doi:10.1001/jamanetworkopen.2026.12133.Association of Glucagon-Like Peptide-1 Receptor Agonists With Risk of Cancers-Evidence From a Drug Target Mendelian Randomization and Clinical Trials. Sun Y, Liu Y, Dian Y, et al. International Journal of Surgery (London, England). 2024;110(8):4688-4694. doi:10.1097/JS9.0000000000001514.GLP-1 receptor agonists and breast cancer risk in type 2 diabetes.. Guo Cheng and Amanda Ward. Journal of Clinical Oncology. 2025;43(Suppl 16):10557. doi:10.1200/JCO.2025.43.16_suppl.10557.Glucagon-Like Peptide-1 Analogues and Risk of Breast Cancer in Women With Type 2 Diabetes: Population Based Cohort Study Using the UK Clinical Practice Research Datalink. Hicks BM, Yin H, Yu OH, et al. BMJ (Clinical Research Ed.). 2016;355:i5340. doi:10.1136/bmj.i5340.GLP-1 Receptor Agonists and Cancer: Current Clinical Evidence and Translational Opportunities for Preclinical Research. Valencia-Rincón E, Rai R, Chandra V, Wellberg EA. The Journal of Clinical Investigation. 2025;135(21):e194743. doi:10.1172/JCI194743.Send us a (voice ) message with this link, we would love to hear from you. Standard message rates may apply.Support the showProduction and Content: Edward Delesky, MD, DABOM & Nicole Aruffo, RNArtwork Rebrand and Avatars:Vantage Design Works (Vanessa Jones) Website: https://www.vantagedesignworks.com/Instagram: https://www.instagram.com/vantagedesignworks?igsh=aHRuOW93dmxuOG9m&utm_source=qrOriginal Artwork Concept: Olivia Pawlowski

By age 35, Javant Benton found himself at a crossroads. He was 85 pounds overweight, prediabetic, prehypertensive, and undergoing tests for cancer. Confronted with his own mortality, he knew something had to change. What began as a personal search for greater well-being became a journey of creativity, discovery, and transformation in the kitchen, where familiar comfort foods were transformed into something nourishing and satisfying.  In this episode, Javant shares the wake-up call that altered his trajectory, the lessons he learned along the way, and how his determination to feel better grew into a community of more than one million followers and a bestselling cookbook that proves eating well doesn't have to mean giving up the foods you love. What we discuss: The health challenges Javant witnessed in his family and how they shaped his view of what was normal. The diets, discoveries, and searches that ultimately led him to a plant-based lifestyle. Javant's favorite healthy sweetener. The mindset and philosophy Javant brings into the kitchen. Blending vs. juicing and the benefits of each. Javant's four pillars of health. The legacy Javant hopes to leave behind. Resources: Make Your Own: 120+ Minimally Processed, Oil-Free, Wheat-Free, Sugar-Free, Plant-based Recipes: Benton, Javant: 9780306836695 Javant's Healthy Vegan Recipes (@healthyveganeating) • Instagram photos and videos HealthyVeganEating - YouTube Healthy Vegan Eating (@100082340305996) - Mentions | Facebook Healthy Vegan Eating https://www.makeyourowncookbook.com/ Click the link below to learn about the FISCAL Act https://switch4good.org/fiscal-act/ Share the website and get your resources here https://kidsandmilk.org/ Dairy-Free Swaps Guide: Easy Anti-Inflammatory Meals, Recipes, and Tips https://switch4good.org/dairy-free-swaps-guide SUPPORT SWITCH4GOOD https://switch4good.org/support-us/ ★☆★ JOIN OUR PRIVATE FACEBOOK GROUP ★☆★  https://www.facebook.com/groups/podcastchat ★☆★ SWITCH4GOOD WEBSITE ★☆★ https://switch4good.org/ ★☆★ ONLINE STORE ★☆★ https://shop.switch4good.org/shop/ ★☆★ FOLLOW US ON INSTAGRAM ★☆★ https://www.instagram.com/Switch4Good/ ★☆★ LIKE US ON FACEBOOK ★☆★ https://www.facebook.com/Switch4Good/ ★☆★ AMAZON STORE ★☆★ https://www.amazon.com/shop/switch4good

Dozens of missiles and drones hit Kyiv and other major cities in Ukraine on Tuesday. More than a dozen people were killed and 100 injured in the attacks. Russia says it was in response to what it called "terrorist acts." Ramy Inocencio has the latest. Researchers from Penn Medicine found women taking GLP-1 drugs are less likely to be diagnosed with breast cancer. Dr. Celine Gounder breaks down the study's findings and if the drugs caused the difference. A man tried to force his way into pop star Sabrina Carpenter's home in Los Angeles after weeks of watching the property, officials say. On Monday, the singer was granted a temporary restraining order against the man. Serena Williams, the 23-time Grand Slam winner, confirmed her highly anticipated return to tennis in a video she posted on Instagram on Monday. Williams, who will play doubles next week, hasn't competed since 2022. Jericka Duncan reports. A new report finds summer hiring for teens is expected to fall to its lowest level in nearly 80 years. Harvard economist and CBS News contributor Roland Fryer explains what's driving the decline. Former Vice President Mike Pence joins "CBS Mornings" to discuss President Trump's policies and popularity among Republicans, personal values in politics today and who he supports in the Texas Senate race. Grammy Award winner P!nk is preparing to host the Tony Awards on Sunday on CBS. The singer speaks with "CBS Mornings" about what to expect and why she asked her daughter for permission before agreeing to host.

What if you're considered “too young” for breast cancer… but your risk says otherwise?In this episode of Test Those Breasts, Jamie sits down with Ashley Flurry, registered mammography technologist and founder of Breast Imaging Matters Outreach, to talk about one of the biggest gaps in breast health: helping women understand their breast cancer risk before age 40.Together, they discuss:

Dr. Abud Bakri, MD, is a board-certified internal medicine physician and expert in the science and clinical use of peptides. We discuss the history, uses, sourcing and safety of BPC-157, GHK-Cu, pinealon, epithalon, GLP-1s, retatrutide, melanotan and growth hormone-promoting peptides. We discuss the gap that exists between animal and human data and meaningful differences in the sources for different peptides. For those interested in peptides, Dr. Bakri provides a grounded look at the science, risks and uncertainties shaping the field today. Read the show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Eight Sleep: https://eightsleep.com/huberman Lingo: https://hellolingo.com/huberman Function: https://functionhealth.com/huberman LMNT: https://drinklmnt.com/huberman Timestamps (00:00:00) Abud Bakri (00:03:33) What are Peptides?, Receptors (00:06:26) BPC-157, Discovery, Animal Proteins (00:11:19) BPC-157, Animal Data, Regeneration (00:12:27) Sponsors: Eight Sleep & Lingo (00:14:51) BPC-157, Regeneration & Healing, Neurological Effects (00:19:27) Adverse Events, Clinical Trials & Legality of BPC-157 (00:29:41) GLPs & Compounding Pharmacy; Peptides & Gray Market (00:35:25) Manufacturing, Compounding Pharmacies, Gray Market, Black Market (00:41:32) Peptides & Tumor Growth?; Angiogenesis (00:45:17) Sponsor: AG1 (00:47:01) Pharmaceutical Patents, Clinical Trials for BPC-157, Potential Outcomes (00:54:19) BPC-157 Healing, Patient Experiences (01:01:22) Physician Counsel, FDA Legality, Malpractice (01:07:25) Pinealon, Epithalon, Discovery; Sleep & Cognitive Performance, Risks (01:18:17) Sponsor: Function (01:19:55) Pineal Age Deterioration, Epithalon, Eye Health (01:29:38) Thymus, Age Shrinkage; Thymosin Alpha-1, Immune Function (01:38:13) TB-500; Pet Health; Thymic Peptide Doses, Thymulin, Zinc (01:49:13) Sponsor: LMNT (01:50:33) GHK-Cu (Copper GHK), Collagen (01:55:32) Illness Recovery, Thymic Score, Tool: Blood Test & Immune Cell Counts (02:04:01) Growth Hormone Secretagogues, Age Decline, Cancer Risk, Insulin (02:15:36) GHK-Cu, Topical Cream, Red Light Therapy (02:20:25) GLPs, Discovery, Physical & Cognitive Long-Term Effects, Fertility (02:33:53) Retatrutide; Drug Patents & Nomenclature (02:39:03) Peptides: Women Reproductive Disorders; TBI, Neurologic Effect; Safe Sources (02:45:34) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Have you had breast cancer and been told you can never, ever touch hormones again? Or are you going through menopause with zero options because your doctor is too scared to even have the conversation?  We cover: Why the science on estrogen and breast cancer has been misrepresented, and what the real data actually shows How testosterone could be the most protective hormone for women with or after breast cancer What inflammatory markers your doctor probably isn't checking, and why they matter more than you think The course being created to train doctors to prescribe hormones safely to high-risk women, so you finally have somewhere to go Why combining conventional cancer care with functional medicine is where the best outcomes actually happen   Everything Breast Cancer Program EBC100ZORA for $100 off Dr. Berkson's Substack: https://substack.com/@drlindseyberkson Past episode with Dr. Lindsey Berkson (Estrogen and Cancer Risk) : https://podcasts.apple.com/us/podcast/long-standing-menopause-doctor-explains-estrogen-and/id1531105768?i=1000737786111 Contact Dr. Lindsey Berkson Email: https://drlindseyberkson.com/contact-dr-berkson/ Website: https://drlindseyberkson.com/ Facebook: www.facebook.com/Dr.LindseyBerkson/ Instagram: www.instagram.com/dlberkson/ Twitter: www.twitter.com/berksonhealth Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here - https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - https://www.oxfordhealthspan.com/ZORA Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try MitoQ for optimal mitochondrial health. Code ZORA for 20% off https://mitoq.com/zora   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠   Biohacking Menopause Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠    For partnership inquiries: https://www.category3.ca/  Some episodes of Hack My Age are supported by partners whose products or services may be discussed during the show. The host may receive compensation or earn a minor commission if you purchase through affiliate links at no extra cost to you. All opinions shared are those of the host and guests, based on personal experience and research, and do not necessarily represent the views of any sponsor. Sponsorships do not imply medical endorsement or approval by any healthcare provider featured on this podcast.

What exactly is Barrett's esophagus—and how do doctors determine who may be at higher risk? In Part 2 of this 4-part patient education series, leading gastroenterologist and advanced endoscopist Raman Muthusamy explains how Barrett's esophagus develops from chronic GERD and how it's diagnosed and evaluated in clinical practice in the United States. In this episode, you'll learn: ✔️ What Barrett's esophagus is ✔️ How chronic acid reflux can affect the esophagus ✔️ How Barrett's is diagnosed during endoscopy ✔️ How doctors assess risk for progression to cancer ✔️ Why early detection matters ✔️ How GI specialists guide treatment and follow-up care If you or someone you love experiences long-standing heartburn, reflux, or GERD symptoms, this episode provides trusted, expert-backed information to help you better understand Barrett's esophagus and what comes next. This episode is part of a 4-part patient education series sponsored by Castle Biosciences and produced in collaboration with leading U.S. clinicians dedicated to improving outcomes for patients with Barrett's esophagus.  

→ Get My Brand Masterlist: ⁠⁠https://drchristiangonzalez.com/best-brands-form-2-2/⁠⁠ Episode Description In 2025, researchers published what may be the most important longevity study of the decade. Three years. Over 2,000 participants. A randomized controlled trial. And the results stopped the researchers themselves. A 61% reduction in invasive cancer risk. A 39% reduction in becoming physically frail. And measurable slowing of biological aging, verified by epigenetic clocks, the most sophisticated tool science has for measuring how fast your cells are actually aging. These were not elite athletes. They were regular older adults. And the three things that produced these results are inexpensive, accessible, and available at any supplement store. Most people are either missing them entirely or doing them in a way that produces almost no benefit. Dr. G breaks down exactly what the study found and what you need to do with it. In this episode, you'll learn:  • Why omega-3 deficiency carries a mortality risk comparable to smoking, and the specific EPA and DHA dose that the research shows actually slows biological aging at the cellular level  • Why vitamin D is not optional if you exercise, and why low vitamin D means the training you are already doing is producing a fraction of the benefit it should  • Why the combination of all three produces results that are not additive but multiplicative, and what that means for anyone over 40 who wants to change their biological trajectory The window that matters most is not when you are 60. It is now. Timestamps: 0:00 - Intro 1:38 - Why This Study Deserves Your Attention (And Why No One Is Talking About It)  3:02 - Who This Episode Is For: Men Over 40 and the People Who Love Them  4:45 - The Deficiency Crisis: Most People Are Missing All Three Interventions  6:29 - Thing #1: Why Low Levels Are as Dangerous as Smoking  8:44 - Thing #2: The Pro-Hormone Your Muscles and Immune System Are Waiting For  10:37 - Thing #3: The One Thing That Is Not Optional for Healthy Aging 13:22 - What Happens When You Do All Three Together (The Numbers Are Dramatic)  14:48 - Exactly What to Take, How Much & How Often Learn more about your ad choices. Visit megaphone.fm/adchoices

There's a surgery to remove the fallopian tubes as a permanent method of birth control that could also reduce a woman's risk of the most common ovarian cancer. But a group of B.C. researchers and physicians say the procedure isn't widely known across Canada. They're trying to change that.

This episode of the PeerDirect Medical News Podcast explores promising new data on the oral pan-RAS inhibitor daraxonrasib in KRAS-mutated pancreatic cancer, a randomized stroke trial evaluating adjunctive tirofiban after tenecteplase, and AI-driven breast cancer risk prediction models that may outperform breast density alone. Together, these studies highlight emerging advances in targeted oncology, acute stroke management, and precision screening technologies that could influence future clinical practice.

Monday, May 18. The seven stories you need to know today.Read today's briefing.

Go to my sponsor https://trylco.com/liveleanaging and use code liveleanaging to get 20% off select tests, including the Healthy Aging Test. Disclaimer: When my dad was diagnosed with cancer, I did what I always do, I went deep into the research to learn what I could do to lower my own risk. This video is the result of that. I'm not a doctor and this is not medical advice, but I believe this information is too important not to share. Always work with your healthcare provider. ► Free 7 Day Trial To My Workout App: https://www.liveleantv.com ► Live Lean Body Quiz: https://www.liveleantv.com/quiz ► Free 7 Day Meal Plan And Recipes: https://www.liveleantv.com/free-stuff When most men think about cancer risk, they think genetics and bad luck. But there's a metabolic side to cancer risk that almost nobody talks about, and it's largely within your control. In this video, I break down exactly how excess body fat, high insulin levels, and chronic inflammation are quietly fueling cancer risk for millions of men, and what you can actually do about it. ⏱ TIMESTAMPS 00:00 Intro 00:48 Obesity Significantly Increases Your Risk For Certain Cancers 01:38 Diabetes Significantly Increases Your Risk For Certain Cancers 02:38 How Excessive Insulin Feeds Cancer Growth 03:27 How Belly Fat Is Fueling Cancer Risk 06:34 The Cancer Risks You Can Control 07:23 The Diet That Starves Cancer Risk 08:40 Here's Your Anti-Cancer Action Plan

We all know drinking alcohol is bad for our health, but how much can it reduce our risk of cancer if we drink less or even cut it out entirely? This week, Dr. Sanjay Gupta digs into the correlation between consuming alcohol and risk of cancer as well as alternatives to alcohol if you're feeling pressured to drink. Plus, we explain if silicone is a better alternative to replace plastic and what the differences between these two materials are.  This episode was produced by Leying Tang  Showrunner: Amanda Sealy  Senior Producer: Dan Bloom  Technical Director: Dan Dzula  Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this transformative episode  host Myrna Young invites Sylvie Beljanski, a leading voice in integrative cancer research, for a poignant discussion about the intertwined roles of emotional well-being and physical health in cancer treatment. This enlightening conversation challenges conventional perspectives, highlighting how emotions such as fear, stress, and chronic psychological trauma can significantly impact cancer risk and recovery.Sylvie dives deep into the holistic approach to cancer treatment, emphasizing the power of plant-based solutions and the importance of emotional healing alongside conventional therapies like chemotherapy. She shares personal anecdotes of her family's experience with the medical industry, illustrating the essential need for patients to be empowered and informed about their choices. Through education and awareness, Sylvie advocates for a multifaceted treatment strategy that respects the patient's emotional and psychological journey, not just the physical symptoms.Timestamp Summary0:02 The Emotional Connection to Cancer and Holistic Healing14:23 Balancing Emotions, Nutrition, and Medical Decisions in Cancer Prevention21:41 Boost Energy and Focus with Spark Energy Focus24:52 Empowering Cancer Patients Through Emotional and Holistic Healing34:52 Transforming Trauma Through Perspective Shifts37:19 Transforming Trauma and Anger Into Purposeful Service43:37 Integrative Approaches and Plant-Based Solutions in Cancer Treatment58:32 Healing Cancer Through Emotional Well-Being and Integrative ApproachesResources:Beljanski Foundation: beljanski.orgIntegrative Cancer Conference: integrativecancerconference.comSponsors of this podcastSpark Energy + Focus is your go-to pre-workout ritual when you need reliable energy to power through the day. drinkspark.com and use code TRANSFORM for 30% off and free shipping With Wegovy at Hers, lose up to 20% or more of your body weight when combined with diet and exercise.  Visit forhers.com/transform to get personalized, affordable care that gets you. See this video on The Transform Your Mind YouTube Channel https://www.youtube.com/@MyhelpsUs/videosTo see a transcripts of this audio as well as links to all the advertisers on the show page https://myhelps.us/Follow Transform Your Mind on Instagram https://www.instagram.com/myrnamyoung/Follow Transform Your mind on Facebookhttps://www.facebook.com/profile.php?id=100063738390977Please leave a rating and review on iTunes https://podcasts.apple.com/us/podcast/transform-your-mind/id1144973094Feedspot Top 100 Mental Health Podcast For sponsored Brand interviews and sponsorship inquires please visit Partner With The Transform Your Mind Podcast | Myrna Young Life Coach

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Dr. Rhonda Patrick, PhD, is a biomedical scientist and public science educator. She shares the exercise, nutrition, supplementation and lifestyle practices linked to better health and lower disease risk including specific cardio and resistance training routines, when and why to do intermittent fasting, ways to lower visceral fat, omega-3 sourcing, creatine for brain and muscle and peptides such as BPC-157. It's broad and thorough coverage of how to build a total health program tailored to your goals and individual biology. Read the show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Our Place: https://fromourplace.com/huberman Lingo: https://hellolingo.com/huberman LMNT: https://drinklmnt.com/huberman Function: https://functionhealth.com/huberman Mateina: https://drinkmateina.com/huberman Timestamps 00:00:00 Rhonda Patrick (00:02:40) Competition, Jumping Rope, Rope Flow (00:06:49) Rhonda's Exercise Routine, Cardiovascular & Resistance Training (00:12:30) Cognitive & Physical Benefits of Exercise, Serotonin & Impulse Control (00:14:40) Sponsors: Our Place & Lingo (00:17:03) Phones While Training? (00:18:45) Rhonda's Strength Training, Low-Reps, Modifications, Mental Resilience (00:27:00) Daily Protein Intake, Intermittent Fasting, Processed Carbohydrates (00:33:32) Lipopolysaccharide (LPS); Gut Permeability, Gluten; Cardiovascular Health (00:42:58) Sponsor: AG1 (00:44:21) Tight Junctions, Gut, Neuroinflammation (00:47:26) L-glutamine, Immune System, Cancer Risk (00:54:55) N-acetylcysteine (NAC), Vitamin E; Antioxidant Balance, Reductive Stress (01:00:08) Starch, Tool: Bedtime Fast & Cardiovascular Health (01:03:36) Cortisol, Intermittent Fasting Benefits (01:08:09) Cortisol, Train Fasted?; Hormones, Visceral Fat (01:13:35) Visceral Fat, Perimenopause/Menopause, Insulin Resistance in Brain & Body (01:21:13) Sponsor: LMNT (01:22:33) Cortisol & Sleep (01:25:42) Intermittent Fasting, Metabolic Switch, Ketones, Muscle Loss? (01:36:47) Tools: Logic-Based Habits; Daily Metabolic Switch; Exercise, Autophagy (01:45:06) Exercise After Poor Sleep?; Training Breaks (01:52:47) Tool: "Exercise Snacks"; Sedentary Lifestyle & Cardiorespiratory Fitness (02:03:31) Sponsor: Function (02:05:16) Creatine, Dose, Resistance Training, Cognitive Function (02:17:43) Biology; Creatine; Supplement Safety (02:25:18) Omega-3s, Inflammation, Cancer Risk, Vitamin D; Trans Fat (02:36:52) Magnesium Threonate vs Bisglycinate, Sleep, Cognitive Benefit; Vitamin D (02:45:46) Supplement Types, Multivitamin, Coenzyme Q10, Urolithin A, Sulforaphane (02:55:10) Microplastics (02:57:26) Sponsor: Mateina (02:58:28) BPC-157, NMN, NR, Tool: Evaluating Supplements, Safety, Sources (03:06:28) L-Carnitine, Alpha-GPC, Nicotine, GABA & Ketogenic Diet (03:15:20) Nattokinase; Microplastics, Water Bottles; Seed Oils (03:22:21) Sauna, Creatine for Kids?, Bananas, Tool: Evaluating Studies (03:28:37) Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices